Nippon India Pharma Fund - Direct Plan - Growth Plan
Nippon India Pharma Fund - Direct Plan - Growth Plan

Nippon India Pharma Fund - Direct Plan - Growth Plan

Equity
Direct
Very High Risk
Sector - Healthcare

NAV: ₹ 309.7 as on 25-01-2022

About the Fund

Nippon India Pharma Fund - Direct Plan - Growth Plan is an equity fund. This fund was started on  1 January, 2013. The fund is managed by Sailesh Raj Bhan, Kinjal Desai. The fund could potentially beat inflation in the long-run.

Key parameters

1) Nippon India Pharma Fund - Direct Plan - Growth Plan has a NAV of 309.6557 as on 27-Jan-2022.

2) Nippon India Pharma Fund - Direct Plan - Growth Plan has 5397 Cr worth of assets under management (AUM) as on 27-Jan-2022 and is more than category average.

3) The fund has an expense ratio 1.03 %.

Fund Overview

Expense ratio
Expense ratio
1.03%
Benchmark
Benchmark
S&P BSE Healthcare PR
AUM
AUM
₹5397 Cr
Inception Date
Inception Date
1 January, 2013
Min Lumpsum/SIP
Min Lumpsum/SIP
₹5000/₹100
Exit Load
Exit Load
1%
Lock In
Lock In
No Lock-in
TurnOver
TurnOver
55.36%

Fund Distribution

  • Equity 99.1%
  • Debt & Cash 0.9%
Size breakup
Large cap
54.5%
Mid cap
29.1%
Small cap
15.5%
Sector Allocation
Health100%

Top Holdings

  • All
  • Equity
  • Debt & Cash
Total Holdings20
Equity Holdings20
Debt Holdings3
Sun Pharmaceuticals Industries Ltd
Sun Pharmaceuticals Industries Ltd
11.9%
Dr Reddy's Laboratories Ltd
Dr Reddy's Laboratories Ltd
9.5%
Cipla Ltd
Cipla Ltd
8.7%
Aurobindo Pharma Ltd
Aurobindo Pharma Ltd
7.6%
Lupin Ltd
Lupin Ltd
7.4%
Divi's Laboratories Ltd
Divi's Laboratories Ltd
6.9%
Torrent Pharmaceuticals Ltd
Torrent Pharmaceuticals Ltd
5.8%
Narayana Hrudayalaya Ltd
Narayana Hrudayalaya Ltd
5.8%

Fund Highlights

About the fund

About the fund

This fund has delivered an average annual returns of 17.87% since inception which is less than its category average return of 27.67%
Fund Allocations

Fund Allocations

This fund has an allocation of 99.11315% in Equity, 0% in Debt and 0.88685% in Cash related instruments
AUM size ₹5397 Cr

AUM size ₹5397 Cr

This fund has AUM of ₹5397 Cr which is more than its category average of ₹ 1615 Cr
Expense Ratio 1.03%

Expense Ratio 1.03%

This fund has an expense ratio of 1.03% which is less than its category average expense ratio of 1.55%

AMC details

Fund House
Nippon Life India Asset Management Ltd
Email
customer_care@reliancemutual.com
Phone
+912230994600/30301111
Address
Reliance Capital Asset Management Ltd.,One India Bulls Centre - Tower One,,11th & 12th floor, Jupiter Mills Compound,,Elphinstone Road,

Frequently Asked Questions

What are the average returns of Nippon India Pharma Fund - Direct Plan - Growth Plan Fund ?

What is the current NAV of Nippon India Pharma Fund - Direct Plan - Growth Plan Fund?

How do I invest in Nippon India Pharma Fund - Direct Plan - Growth Plan Fund?

What is the expense ratio of Nippon India Pharma Fund - Direct Plan - Growth Plan fund?

What is the worth of total assets under management (AUM) of Nippon India Pharma Fund - Direct Plan - Growth Plan fund ?

What are the top holdings of Nippon India Pharma Fund - Direct Plan - Growth Plan Fund?

What are the top sectors Nippon India Pharma Fund - Direct Plan - Growth Plan Fund has invested in?